in Health care
Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection
Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isoproterenol Hydrochloride Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials (USRLD: Isuprel Injection). Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock […] More
